Cargando…

Inflammation and Insulin Resistance as Risk Factors and Potential Therapeutic Targets for Alzheimer’s Disease

Overnutrition and modern diets containing high proportions of saturated fat are among the major factors contributing to a low-grade state of inflammation, hyperglycemia and dyslipidemia. In the last decades, the global rise of type 2 diabetes and obesity prevalence has elicited a great interest in u...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vinuesa, Angeles, Pomilio, Carlos, Gregosa, Amal, Bentivegna, Melisa, Presa, Jessica, Bellotto, Melina, Saravia, Flavia, Beauquis, Juan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8102834/ https://www.ncbi.nlm.nih.gov/pubmed/33967682 http://dx.doi.org/10.3389/fnins.2021.653651

Ejemplares similares

Short-Term Environmental Enrichment Enhances Adult Neurogenesis, Vascular Network and Dendritic Complexity in the Hippocampus of Type 1 Diabetic Mice
por: Beauquis, Juan, et al.
Publicado: (2010)

Vasculo-Neuronal Coupling and Neurovascular Coupling at the Neurovascular Unit: Impact of Hypertension
por: Presa, Jessica L., et al.
Publicado: (2020)

Deregulation of Mitochondria-Shaping Proteins Opa-1 and Drp-1 in Manganese-Induced Apoptosis
por: Alaimo, Agustina, et al.
Publicado: (2014)

Insulin Resistance in Alzheimer's Disease
por: Ferreira, Laís S. S., et al.
Publicado: (2018)

Insulin Resistance as a Therapeutic Target in the Treatment of Alzheimer's Disease: A State-of-the-Art Review
por: Benedict, Christian, et al.
Publicado: (2018)

Insulin Resistance and Alzheimer’s Disease: Bioenergetic Linkages
por: Neth, Bryan J., et al.
Publicado: (2017)

The Involvement of Peripheral and Brain Insulin Resistance in Late Onset Alzheimer’s Dementia
por: Folch, Jaume, et al.
Publicado: (2019)

Insulin Resistance Exacerbates Alzheimer Disease via Multiple Mechanisms
por: Wei, Zenghui, et al.
Publicado: (2021)

Epigenetic Modifications in Alzheimer’s Neuropathology and Therapeutics
por: Esposito, Michelle, et al.
Publicado: (2019)

Microglia and Wnt Pathways: Prospects for Inflammation in Alzheimer’s Disease
por: Yang, Yunying, et al.
Publicado: (2020)

Insulin Signaling Impairment in the Brain as a Risk Factor in Alzheimer’s Disease
por: Hölscher, Christian
Publicado: (2019)

Nanoliposomes as a Therapeutic Tool for Alzheimer’s Disease
por: Ordóñez-Gutiérrez, Lara, et al.
Publicado: (2020)

Menopause, obesity and inflammation: interactive risk factors for Alzheimer’s disease
por: Christensen, Amy, et al.
Publicado: (2015)

Bioenergetic Dysfunction and Inflammation in Alzheimer’s Disease: A Possible Connection
por: Wilkins, Heather M., et al.
Publicado: (2014)

Increased White Matter Inflammation in Aging- and Alzheimer’s Disease Brain
por: Raj, Divya, et al.
Publicado: (2017)

Microglia-Mediated Inflammation and Neural Stem Cell Differentiation in Alzheimer’s Disease: Possible Therapeutic Role of K(V)1.3 Channel Blockade
por: Revuelta, Miren, et al.
Publicado: (2022)

The Link Between Tau and Insulin Signaling: Implications for Alzheimer’s Disease and Other Tauopathies
por: Gonçalves, Rafaella Araujo, et al.
Publicado: (2019)

Clinical antidiabetic medication used in Alzheimer’s disease: From basic discovery to therapeutics development
por: Huang, Juan, et al.
Publicado: (2023)

NSAIDs: How they Work and their Prospects as Therapeutics in Alzheimer's Disease
por: Sastre, Magdalena, et al.
Publicado: (2010)

Fluid Biomarkers in Clinical Trials of Alzheimer’s Disease Therapeutics
por: Ritter, Aaron, et al.
Publicado: (2015)

The Contribution and Therapeutic Potential of Epigenetic Modifications in Alzheimer’s Disease
por: Wood, Ian C.
Publicado: (2018)

Iron and Alzheimer’s Disease: From Pathogenesis to Therapeutic Implications
por: Liu, Jun-Lin, et al.
Publicado: (2018)

Gamma Oscillations in Alzheimer’s Disease and Their Potential Therapeutic Role
por: Traikapi, Artemis, et al.
Publicado: (2021)

Pyroptosis as a candidate therapeutic target for Alzheimer’s disease
por: Huang, Yuehua, et al.
Publicado: (2022)

Microglia in Alzheimer’s disease: pathogenesis, mechanisms, and therapeutic potentials
por: Miao, Jifei, et al.
Publicado: (2023)

Insulin Resistance as a Link between Amyloid-Beta and Tau Pathologies in Alzheimer’s Disease
por: Mullins, Roger J., et al.
Publicado: (2017)

MTOR-DRIVEN ALTERATIONS IN THE BRAIN MICROVASCULAR PROTEOME IN ALZHEIMER’S DISEASE
por: Banh, Andy, et al.
Publicado: (2019)

New Therapeutic Approaches for Alzheimer’s Disease and Cerebral Amyloid Angiopathy
por: Saito, Satoshi, et al.
Publicado: (2014)

Autophagy and Alzheimer’s Disease: From Molecular Mechanisms to Therapeutic Implications
por: Uddin, Md. Sahab, et al.
Publicado: (2018)

The Case for Abandoning Therapeutic Chelation of Copper Ions in Alzheimer's Disease
por: Drew, Simon C.
Publicado: (2017)

APOE and Alzheimer’s Disease: From Lipid Transport to Physiopathology and Therapeutics
por: Husain, Mohammed Amir, et al.
Publicado: (2021)

Therapeutic properties of multi-cannabinoid treatment strategies for Alzheimer’s disease
por: Coles, Madilyn, et al.
Publicado: (2022)

Editorial: Mechanisms, markers and therapeutics of synaptic pathology in Alzheimer's disease
por: Metaxas, Athanasios, et al.
Publicado: (2022)

Suppressor of Cytokine Signaling 3: Emerging Role Linking Central Insulin Resistance and Alzheimer’s Disease
por: Cao, Lan, et al.
Publicado: (2018)

Inflammation: Bridging Age, Menopause and APOEε4 Genotype to Alzheimer’s Disease
por: Mishra, Aarti, et al.
Publicado: (2018)

Infection-Induced Systemic Inflammation Is a Potential Driver of Alzheimer's Disease Progression
por: Giridharan, Vijayasree V., et al.
Publicado: (2019)

Frontiers in therapeutic development of allopregnanolone for Alzheimer’s disease and other neurological disorders
por: Irwin, Ronald W., et al.
Publicado: (2014)

The Adenosinergic Signaling: A Complex but Promising Therapeutic Target for Alzheimer’s Disease
por: Cellai, Lucrezia, et al.
Publicado: (2018)

Commentary: The Case for Abandoning Therapeutic Chelation of Copper Ions in Alzheimer’s Disease
por: Squitti, Rosanna, et al.
Publicado: (2017)

Targeting TNFR2 as a Novel Therapeutic Strategy for Alzheimer’s Disease
por: Ortí-Casañ, Natalia, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_d7fg0g36r8nm692e8u2rupde4t